ArticleAmerican journal of blood research2021

Ibrutinib in patients with relapsed/refractory mantle cell lymphoma: a real-life, retrospective, multicenter trial on behalf of the "RTL" (regional Tuscan lymphoma network).

Emanuele Cencini et al.PubMed ↗Full text ↗

No numbers read from the abstract.